RTW Investments Overview
- Investor Type
-
Hedge Fund
- Status
-
Active
- Professionals
-
12

- Investments
-
97
- Portfolio
-
35
- Exits
-
53

RTW Investments General Information
Description
Founded in 2009, RTW Investments is a hedge fund manager headquartered in New York, New York. The firm primarily focuses on a sector-oriented strategy focusing on life sciences, big data, and digital health sectors across the United States and Europe.
Contact Information
Website
www.rtwfunds.com
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Other Investor Types
Venture Capital
Primary Office
- 40 10th Avenue
- Floor 7
- New York, NY 10014
- United States
+1 (646) 000-0000
RTW Investments Investments (97)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Abdera Therapeutics | 04-Apr-2023 | Early Stage VC | 00000 | Drug Discovery | Pre-Clinical Trials | |
000000000 00000000 | 28-Mar-2023 | 0000 | 000.00 | Pharmaceuticals | Generating Revenue | |
0000 000000000000 | 06-Mar-2023 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 3 | |
0000000 0000000000 | 21-Feb-2023 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - General | |
00000000 000000000 | 09-Feb-2023 | 0000 | Therapeutic Devices | Generating Revenue | ||
00000 000000000000 | 18-Jan-2023 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | |
000000 00000000000 | 07-Dec-2022 | 00000 00000 | 00000 | Biotechnology | Pre-Clinical Trials | |
00000 0000 0000000 | 05-Dec-2022 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | |
Immunic Therapeutics | 12-Oct-2022 | PIPE | 0000 | Drug Discovery | Generating Revenue | |
Allakos | 21-Sep-2022 | PIPE | 00000 | Drug Delivery | Generating Revenue |
RTW Investments Exits (53)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
ACELYRIN | 05-May-2023 | IPO | 00000 |
000000000 | 10-Feb-2023 | 000 | 00000 |
000000 00000000 00 | 27-Jan-2023 | 000000000000000000 | |
000000000 000000 | 26-Jan-2023 | 0000000 000000 | 0000 |
000000000 | 01-Dec-2022 | 000000000000000000 | 0000 |
00 00000 000000000 | 22-Aug-2022 | 000000000000000000 | 00000 |
00000000 000000000 | 06-Apr-2022 | 0000000 000000 | 00000 |
000000 000000 | 07-Jan-2022 | 000 | 00000 |
Ventyx Biosciences | 21-Oct-2021 | IPO | 00000 |
Pyxis Oncology | 08-Oct-2021 | IPO | 00000 |
RTW Investments Investments by Industry, Year, and Region
RTW Investments Team (26)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Robert Aurigema | Chief Financial Officer | New York, NY | |||
Nathan Pelsma | Chief Operating Officer | New York, NY | |||
Paul Lu Ph.D | Managing Director & Head, Business Development | New York, NY | |||
Joshua Kennedy-Smith Ph.D | Managing Director & Research Analyst | New York, NY | |||
Piratip Pratumsuwan | Managing Director & Research Analyst | 0 | 0 | New York, NY |
RTW Investments Co-Investors (248)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Perceptive Advisors | 12 | 0 | 0 |
![]() |
![]() |
Cormorant Asset Management | 00 | 0 |
![]() |
![]() |
|
RA Capital Management | 00 | 0 |
![]() |
![]() |
|
Janus Henderson Investors | 00 | 0 |
![]() |
![]() |
|
Logos Capital | 0 | 0 |
![]() |
![]() |